Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case report of acute right ventricular failure in a patient undergoing transoesophageal echocardiogram for evaluation of tricuspid regurgitation.

European heart journal. Case reports·2026
Same author

Corneal Innervation Research at a Crossroads: A Tool-Driven Roadmap for the Future.

Investigative ophthalmology & visual science·2026
Same author

Changes in Melanopsin expression in the iris after corneal abrasion in an experimental rat model.

Experimental eye research·2026
Same author

Incidence and Outcomes of Unstable Angina in Patients with Low High-Sensitivity Cardiac Troponin I Values-A Substudy of the RACE-IT Trial.

Journal of clinical medicine·2026
Same author

Spatial transcriptomic mapping of canine osteosarcoma reveals immune microenvironment features linked to survival.

Communications biology·2026
Same author

Prognostic Significance of Right Ventricle-Pulmonary Artery Coupling to Risk Stratify Patients Undergoing Transesophageal Echocardiogram For Severe Tricuspid Regurgitation.

The American journal of cardiology·2026
Same journal

Presumed Bilateral Retinitis Associated with JC Virus in a Patient with HIV AIDS.

Ocular immunology and inflammation·2026
Same journal

Safety and Efficacy of Adalimumab in the Treatment of Refractory Behçet's Uveitis: A Prospective Cohort Study.

Ocular immunology and inflammation·2026
Same journal

Role of Adjunctive Intravitreal Therapy in Intraocular Tubercular Granuloma at a Tertiary Uveitis Care Centre - A Retrospective Case Series.

Ocular immunology and inflammation·2026
Same journal

Sex Differences in Uveitis Etiology: A Systematic Review and Meta-Analysis.

Ocular immunology and inflammation·2026
Same journal

Upadacitinib in Refractory Vogt-Koyanagi-Harada Disease: A Case Report.

Ocular immunology and inflammation·2026
Same journal

Choroidal and Retinal Imaging Findings in Childhood-Onset Mevalonate Kinase Deficiency: An OCT-Based Case-Control Study.

Ocular immunology and inflammation·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K

Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Decrease the Development of Severe Experimental

Yu Qin1, Ann M Chan1, Yu-Ling Chang2

  • 1a Department of Ophthalmology , Stein Eye Institute , Los Angeles , California , USA.

Ocular Immunology and Inflammation
|September 16, 2017
PubMed
Summary
This summary is machine-generated.

Early treatment with human embryonic stem cell-derived mesenchymal stromal cells (hESC-MSCs) reduced experimental autoimmune uveitis (EAU) in mice. This immune modulation therapy shows promise for treating severe uveitis.

Keywords:
CytokineEAUMSClight sensitivity assayuveitis

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

18.2K

Related Experiment Videos

Last Updated: Feb 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.2K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.3K
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE
09:24

Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE

Published on: April 15, 2014

18.2K

Area of Science:

  • Immunology
  • Ophthalmology
  • Regenerative Medicine

Background:

  • Experimental autoimmune uveitis (EAU) is a severe autoimmune eye disease.
  • Murine models like B10.RIII mice are crucial for studying EAU pathogenesis.
  • Mesenchymal stromal cells (MSCs) are investigated for their immunomodulatory properties.

Purpose of the Study:

  • To evaluate the therapeutic potential of human embryonic stem cell-derived mesenchymal stromal cells (hESC-MSCs) in a murine model of EAU.
  • To assess the impact of early systemic hESC-MSC administration on EAU development.
  • To understand the immunological mechanisms underlying hESC-MSC treatment in EAU.

Main Methods:

  • B10.RIII mice were immunized with an uveitogenic peptide to induce EAU.
  • Intraperitoneal injections of hESC-MSCs (5 million/animal) were administered on the day of immunization.
  • Disease severity was assessed via behavioral light sensitivity assays and histological evaluation.
  • Splenocyte cytokine production (Th1, Th2, Th17) and regulatory T cell populations were analyzed.

Main Results:

  • Early systemic hESC-MSC treatment significantly reduced the development of severe EAU in B10.RIII mice.
  • hESC-MSCs suppressed Th17 responses while upregulating Th1 and Th2 responses.
  • Treatment led to increased production of IL-2 and GM-CSF in splenocytes.

Conclusions:

  • hESC-MSCs effectively decrease the development of severe EAU in a murine model.
  • The therapeutic effect is likely mediated by systemic immune modulation.
  • Further research is warranted to explore hESC-MSC efficacy in active EAU.